查看购物车
  • Traditional Chinese
  • English
  • Japanese
维生素 K2 市场规模和预测、全球和地区份额、趋势和成长机会分析报告范围：按产品、剂型、来源、应用和地理位置
市场调查报告书
商品编码
1372526

维生素 K2 市场规模和预测、全球和地区份额、趋势和成长机会分析报告范围：按产品、剂型、来源、应用和地理位置

Vitamin K2 Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product, Dosage Forms, Source, Application, and Geography
出版日期: | 出版商: The Insight Partners | 英文 198 Pages | 订单完成后即时交付

价格

维生素 K2 市场规模预计将从 2022 年的 1.44 亿美元增至 2030 年的 11.6 亿美元；预计2022年至2030年该市场的复合年增长率将达到29.7%。

维生素 K2 市场的成长归因于成人和新生儿心血管疾病盛行率的增加以及骨质疏鬆症病例的增加。然而，人们对维生素 K2 益处的认识有限，阻碍了市场的成长。

CVD 盛行率的增加推动了维生素 K2 市场的成长

心血管疾病（CVD）仍然是一个重大的全球健康问题，近年来其盛行率稳定上升。这种上升是由于人口老化、久坐的生活方式和不良的饮食选择，以及糖尿病、高胆固醇血症和高血压等危险因子的日益普及。据世界卫生组织称，CVD 是死亡的主要原因，全球每年约有 1,790 万人死亡。此外，根据欧洲环境署的数据，每年有超过 600 万人被诊断出 CVD，超过 170 万人死于 CVD，占 2022 年欧盟所有死亡人数的 37%，使其成为主要死因。

研究人员正在探索各种预防和治疗方法来对抗心血管疾病。人们感兴趣的领域之一是维生素 K2 在心血管健康中的潜在作用。维生素 K2 或甲基萘醌是维生素 K 的一种形式，与潜在的心血管益处有关。维生素 K2 影响心血管健康的关键机制是其调节钙代谢的作用。动脉钙化是钙沉积在动脉壁中积聚的过程，会导致动脉粥状硬化的发展，而动脉粥状硬化是心血管疾病的一个主要原因。研究发现，维生素 K2 透过活化有助于调节钙沉积的蛋白质，在抑制动脉钙化方面发挥重要作用，从而降低动脉粥状硬化和相关心血管疾病的风险。

几项观察性研究探讨了维生素 K2 摄取量与 CVD 结局之间的潜在关联。虽然这些研究无法建立明确的因果关係，但它们提供了有趣的见解。 《营养杂誌》的一项研究发现，较高的维生素 K2 摄取量与较低的冠心病死亡率风险有关。此外，维生素 K2 应被视为与生活方式改变一起的潜在辅助治疗或预防措施。这些改变包括采用富含水果、全谷类、蔬菜和瘦蛋白的均衡饮食；保持健康的体重；定期进行体力活动；管理血压和胆固醇水平；以及戒掉吸烟的习惯。因此，CVD 的日益普及正在推动维生素 K2 市场的发展。

维生素 K2 市场：细分概述

维生素 K2 市场根据产品、剂型、来源、应用和地理位置进行细分。

维生素 K2 市场按产品细分为 MK-4、MK-7 和组合药物。 2022年，MK-7细分市场占据最大市场份额，预计2022-2030年复合年增长率最快。 Menaquinone-7 (MK-7) 是一种先进的脂溶性维生素 K2，具有多种身体功能。只有 MK-7 形式的维生素 K2 已被证明每天服用一次即可为骨骼和牙齿提供 24 小时保护。 MK-7 在体内的半衰期比其他形式的维生素 K2 长得多，并且在血液中停留的时间也最长，因为它不仅存在于肝组织中，而且还存在于骨骼、动脉和软组织中。因此，MK-7 补充剂每天只能服用一次。根据 MenaQ7 的说法，每天 45 微克 MK-7 可以增加羧化并激活维生素 K 依赖性蛋白质，例如促进骨骼健康的骨钙素和促进心臟健康的基质 GLA 蛋白 (MGP)。

根据剂型，维生素 K2 市场分为胶囊和片剂、粉末和油。 2022年，粉末细分市场占据最大的市场份额，预计2022-2030年复合年增长率最快。维生素粉在水和其他液体中快速崩解。与水一起服用时，粉末形式的维生素 K2 产品吸收速度更快，并且比胶囊或片剂形式更有效。使用维生素 K2 粉末控制高钙浓度。维生素 K2 有助于减少钙吸收并降低肾结石或骨质疏鬆症的风险。血液稀释药物（抗凝血剂），例如华法林，会引起出血，而维生素 K2 可以阻止并减缓出血。因此，由于这些因素，粉末市场预计在预测期内将大幅成长。

根据来源，维生素 K2 市场分为天然维生素 K2 和合成维生素 K2。 2022年，天然细分市场占据更大的市场份额，预计2022-2030年复合年增长率更快。深色绿叶蔬菜中含有的天然维生素 K2 对于新陈代谢和凝血至关重要。维生素 K2（或甲基萘醌）在内臟和发酵食品中含有少量。肠道细菌也会产生维生素 K2。发酵食品是维生素 K2 的良好来源。内臟和高脂乳製品因其脂溶性而含有大量维生素 K2。人类肠道中的细菌也会产生少量的 K2。

根据应用，维生素 K2 市场分为药品、营养保健品和食品等。 2022年，药品领域占据最大的市场份额，而营养保健品和食品领域预计在2022-2030年期间复合年增长率最快。由于客户对营养和膳食补充剂以解决各种营养缺乏的需求很高，预计营养保健品和食品领域将快速成长。维生素K2作为膳食补充剂添加在食品中以增加其营养价值。根据最终使用方向，维生素 K2 可用于食品、保健和膳食补充剂以及功能性食品。它也存在于一种称为“纳豆”的传统日本菜餚中。纳豆是由使用不同类型的细菌（包括丙酸菌和乳酸菌）发酵的大豆製成的。

维生素 K2 市场：地理概况

根据地理位置，维生素 K2 市场分为五个关键区域：北美、欧洲、亚太地区、南美洲和中美洲以及中东和非洲。 2022年，北美占据了vK2市场的最大份额。预计 2022 年至 2030 年，亚太地区将成为全球 vK2 市场复合年增长率最高的地区。

亚太地区维生素 K2 市场分为中国、日本、印度、韩国、澳洲和亚太其他地区。该地区维生素 K2 市场的成长受到公司之间的合作、心血管疾病 (CVD) 盛行率上升以及人口老化的广泛推动。 2022年4月发表的一篇研究文章《中国心血管疾病死亡率与潜在危险因子》提到，心血管疾病（CVD）是中国严重的医疗负担之一。中国有2.9亿人患有冠心病（1100万）、心臟病（1300万）、心臟衰竭（4.5）、肺心病（500万）、风湿性心臟病（250万）、先天性心臟病（2）百万）和高血压（2.45 亿）。文章也指出，中国的CVD相关死亡率占全球的40%。维生素 K2 透过调节钙稳态，在心血管健康中发挥至关重要的作用。维生素 K2 补充剂透过改变动脉僵硬度和全身钙化与增强心血管结局密切相关。维生素 K2 补充剂价格实惠且安全性已得到美国食品药物管理局 (FDA) 的验证，是增强心血管结局的可行且有利的选择。因此，中国人口中心血管疾病负担和盛行率的增加预计将增加对维生素 K2 补充剂的需求，从而推动市场成长。

一些市场参与者正在采取有机策略来保持市场竞争力。例如，2022年6月，Balchem Corporation宣布完全收购Kappa Bioscience AS。此次收购增加了 Kappa Bioscience AS 的特殊维生素 K2，帮助 Balchem 扩大了其产品组合。

2022 年 10 月，PLT Health Solutions, Inc. 宣布非基因改造专案公司为其 menatto 提供非基因改造验证。 2022 年 3 月，该公司在美国推出了 menatto，该产品由日本东京食用油生产商 J-Oil Mills 生产。

2023 年 5 月，帝斯曼併入芬美意，创建了一个强大的平台，用于重新发明、製造和组合重要的营养素、香精和香料。该公告旨在创建一个名为「帝斯曼芬美意」的新品牌，在该品牌下，两家公司将在营养、健康和美容领域拥有竞争优势和成长机会。

2023 年 4 月，帝斯曼宣布与 Adare Pharma Solutions 进行谈判，以 3.012 亿美元（2.75 亿欧元）收购 Adare Biome。此次收购将使帝斯曼能够扩大人类健康和动物营养产品范围。

目录

第 1 章：简介

  • Insight Partners 研究报告指南
  • 市场区隔

第 2 章：执行摘要

  • 重要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：维生素 K2 市场格局

  • 概述
  • PEST分析
    • 北美 PEST 分析

第 5 章：维生素 K2 市场 - 主要产业动态

  • 主要市场驱动因素：
    • CVD 盛行率增加
    • 成人和新生儿骨质疏鬆症骨变形病例不断增加
  • 市场限制
    • 对维生素 K2 益处的认识有限
  • 市场机会
    • 拓展配销通路
  • 未来的趋势
    • 监管考虑和标准
  • 影响分析：

第 6 章：维生素 K2 市场 - 全球市场分析

  • 维生素 K2 市场收入，2022 - 2030

第 7 章：全球维生素 K2 市场 - 收入和 2030 年预测 - 按产品。

  • 概述
  • 2022 年和 2030 年维生素 K2 市场收入份额（按产品）（%）
  • MK-4
  • MK-7
  • 复方药物

第 8 章：全球维生素 K2 市场 - 2030 年收入和预测 - 按剂型。

  • 概述
  • 2022 年和 2030 年维生素 K2 市场收入份额（按剂型）（%）
  • 胶囊和片剂
  • 粉末
  • 油

第 9 章：全球维生素 K2 市场 - 收入和 2030 年预测 - 按来源。

  • 概述
  • 2022 年和 2030 年维生素 K2 市场收入份额（按来源划分）（%）
  • 自然的
  • 合成的

第 10 章：全球维生素 K2 市场 - 收入和 2030 年预测 -按应用。

  • 概述
  • 2022 年和 2030 年维生素 K2 市场收入份额，按应用划分 (%)
  • 药品
  • 营养保健品和食品
  • 其他的

第 11 章：维生素 K2 市场 - 地理分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 中东和非洲其他地区
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

第 12 章：维生素 K2 市场产业格局

  • 概述
  • 维生素 K2 市场的成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第 13 章：公司简介

  • Lonza Group AG
  • International Flavors & Fragrances Inc
  • Balchem Corp
  • BASF SE
  • Lesaffre et Cie SA
  • Seebio Biotech (Shanghai) Co Ltd
  • Koninklijke DSM NV
  • Novozymes AS
  • Glanbia Plc
  • Anderson Global Group LLC

第 14 章：附录

  • 关于我们
  • 专业术语
Product Code: TIPRE00028583

The vitamin K2 market size is projected to reach US$ 1.160 billions by 2030 from US$ 0.144 billions in 2022; the market is estimated to record a CAGR of 29.7% from 2022 to 2030.

The vitamin K2 market growth is attributed to increasing prevalence of CVD and growing cases of osteoporosis in adults and newborns. However, limited awareness regarding benefits of vitamin K2 is hindering the market growth.

Increasing Prevalence of CVD Propels Vitamin K2 Market Growth

Cardiovascular disease (CVD) continues to be a significant global health concern, with its prevalence steadily increasing in recent years. This rise is due to the aging population, sedentary lifestyles, and poor dietary choices, along with the growing prevalence of risk factors, including diabetes, hypercholesterolemia, and hypertension. According to the World Health Organization, CVD is a leading cause of death, registering ~17.9 million deaths every year globally. Additionally, as per the European Environment Agency, every year, more than 6 million CVD are diagnosed, and over 1.7 million people die from CVD, representing 37% of all deaths in in the European Union in 2022, making it a leading cause of death.

Researchers are exploring various preventive and therapeutic approaches to combat CVD. One area of interest is the potential role of vitamin K2 in cardiovascular health. vitamin K2, or menaquinone, is a form of vitamin K linked to potential cardiovascular benefits. A critical mechanism by which vitamin K2 impacts cardiovascular health is its role in regulating calcium metabolism. Arterial calcification, the process of calcium deposits accumulating in the arterial walls, contributes to the development of atherosclerosis, a major underlying cause of CVD. vitamin K2 has been found to play a significant role in inhibiting arterial calcification by activating proteins that help regulate calcium deposition, thus reducing the risk of atherosclerosis and related cardiovascular disorders.

Several observational studies have examined the potential association between vitamin K2 intake and CVD outcomes. While these studies are unable to establish a definitive cause-and-effect relationship, they have provided interesting insights. A study by the Journal of Nutrition found that higher vitamin K2 intake was linked to a lower risk of coronary heart disease mortality. Further, vitamin K2 should be considered a potential adjunctive therapy or preventive measure alongside lifestyle changes. These modifications include adopting a balanced diet rich in fruits, whole grains, vegetables, and lean proteins; maintaining a healthy weight; engaging in regular physical activity; managing blood pressure and cholesterol levels; and stopping smoking habits. Thus, the increasing prevalence of CVD is driving the vitamin K2 market.

Vitamin K2 Market: Segmental Overview

The vitamin K2 market is segmented on the basis of product, dosage forms, source, application, and geography.

The vitamin K2 market, by product, is segmented into MK-4, MK-7, and combination drugs. In 2022, the MK-7 segment held the largest market share, and it is estimated to register the fastest CAGR during 2022-2030. Menaquinone-7 (MK-7) is an advanced, fat-soluble form of vitamin K2 that serves multiple bodily functions. Only vitamin K2 in the form of MK-7 has been proven to provide 24-hour protection to bones and teeth from a single daily dose. MK-7 has a much longer half-life in the body and stays in the blood the longest than other forms of vitamin K2, owing to its presence not only in liver tissues but also in bones, arteries, and soft tissues. Therefore, MK-7 supplementation must only be taken once daily. According to MenaQ7, 45 mcg of MK-7 per day can increase carboxylation and activate vitamin K-dependent proteins, such as osteocalcin for bone health and Matrix GLA Protein (MGP) for heart health.

Based on dosage forms, the vitamin K2 market is segmented into capsules & tablets, powder, and oils. In 2022, the powder segment held the largest market share, and it is estimated to register the fastest CAGR during 2022-2030. Vitamin powder disintegrates quickly in water and other liquids. When taken with water, vitamin K2 products get absorbed faster in powder form and are more effective than in capsule or tablet form. High calcium level is controlled with vitamin K2 powder. Vitamin K2 helps reduce calcium absorption and lower the risk of developing kidney stones or osteoporosis. Blood-thinning drugs (anticoagulants), such as warfarin, can cause bleeding, which vitamin K2 stops and slows down. Thus, owing to such factors, the powder segment is expected to grow considerably during the forecast period.

Based on source, the vitamin K2 market is bifurcated into natural and synthetic. In 2022, the natural segment held a larger market share and is estimated to register a faster CAGR during 2022-2030. Natural vitamin K2 found in dark leafy greens is essential for metabolism and blood clotting. Vitamin K2, or menaquinone, is present in small amounts in offal and fermented foods. Gut bacteria also produce vitamin K2. Fermented foods are good vitamin K2 sources. Offal and high-fat dairy products contain significant amounts of vitamin K2 because of their fat-soluble properties. Bacteria residing in the human gut also produce small amounts of K2.

Based on application, the vitamin K2 market is segmented into pharmaceuticals, nutraceuticals and food, and others. In 2022, the pharmaceuticals segment held the largest market share, and the nutraceuticals and food segment is estimated to register the fastest CAGR during 2022-2030. The nutraceuticals and food segment is expected to grow rapidly due to high customer demand for nutritional and dietary supplements to address various nutritional deficiencies. Vitamin K2 is added as a dietary supplement in food to increase its nutritional value. Depending on the end-use direction, vitamin K2 can be consumed in food, health and dietary supplements, and functional foods. It is also found in a traditional Japanese dish called "natto." Natto is composed of fermented soybeans using different types of bacteria, including propionic acid bacteria and lactic acid bacteria.

Vitamin K2 Market: Geographical Overview

Based on geography, the vitamin K2 market is segmented into five key regions: North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa. In 2022, North America accounted for the largest share of the vK2 market. Asia Pacific is expected to register the highest CAGR in the global vK2 market during 2022-2030.

The Asia Pacific vitamin K2 market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The growth of the vitamin K2 market in this region is widely driven by collaborations between companies, rising prevalence of cardiovascular disease (CVD), and an increasing aging population. A research article, "Cardiovascular Disease Mortality and Potential Risk Factor in China," published in April 2022, mentioned that cardiovascular disease (CVD) is one of the serious healthcare burdens in China. In China, 290 million people suffer from coronary heart disease (11 million), cardiac disorders (13 million), heart failure (4.5), pulmonary heart disease (5 million), rheumatic heart disease (2.5 million), congenital heart disease (2 million), and hypertension (245 million). The article also states that China accounts for 40% of the total mortality related to CVD globally. Vitamin K2 plays a vital role in cardiovascular health by regulating calcium homeostasis. Vitamin K2 supplements strongly correlate with enhanced cardiovascular outcomes by modifying arterial stiffness and systemic calcification. Supported by its affordability and Food and Drug Administration (FDA)-proven safety, vitamin K2 supplements are a viable and favorable option to enhance cardiovascular outcomes. Thus, the growing burden and prevalence of CVD among the population in China is expected to increase the demand for vitamin K2 supplements, thereby boosting the market growth.

Several market players are adopting organic strategies to stay competitive in the market. For instance, In June 2022, Balchem Corporation announced the complete acquisition of Kappa Bioscience AS. The acquisition has helped Balchem expand its product portfolio by adding Kappa Bioscience AS's specialty vitamin K2.

In October 2022, PLT Health Solutions, Inc. announced that non-GMO Project company offered it non-GMO verification for its menatto. In March 2022, the company introduced menatto in the US, which is manufactured by edible oils producer J-Oil Mills, Tokyo, Japan.

In May 2023, DSM merged into Firmenich to create a robust platform for reinventing, manufacturing, and combining vital nutrients, flavors, and fragrances. The announcement was made to create a new brand called dsm-firmenich, under which the companies will have a competitive edge and growth opportunities for nutrition, health, and beauty segments.

In April 2023, DSM announced negotiations with Adare Pharma Solutions to acquire its Adare Biome for US$ 301.2 million (€275 million). The acquisition will enable DSM to expand its human health and animal nutrition offerings.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the vitamin K2 market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global vitamin K2 market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global vitamin K2 market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution. 

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Vitamin K2 Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis

5. Vitamin K2 Market - Key Industry Dynamics

  • 5.1 Key Market Drivers:
    • 5.1.1 Increasing Prevalence of CVD
    • 5.1.2 Growing Cases of Osteoporosis Bone Deformation in Adults and Newborns
  • 5.2 Market Restraints
    • 5.2.1 Limited Awareness Regarding Benefits of Vitamin K2
  • 5.3 Market Opportunities
    • 5.3.1 Expansion of Distribution Channel
  • 5.4 Future Trends
    • 5.4.1 Regulatory Consideration and Standards
  • 5.5 Impact Analysis:

6. Vitamin K2 Market - Global Market Analysis

  • 6.1 Vitamin K2 Market Revenue (US$ Mn), 2022 - 2030

7. Global Vitamin K2 Market - Revenue and Forecast to 2030 - by Product.

  • 7.1 Overview
  • 7.2 Vitamin K2 Market Revenue Share, by Product 2022 & 2030 (%)
  • 7.3 MK-4
    • 7.3.1 Overview
    • 7.3.2 MK-4: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 MK-7
    • 7.4.1 Overview
    • 7.4.2 MK-7: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Combination Drugs
    • 7.5.1 Overview
    • 7.5.2 Combination Drugs: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)

8. Global Vitamin K2 Market - Revenue and Forecast to 2030 - by Dosage Form.

  • 8.1 Overview
  • 8.2 Vitamin K2 Market Revenue Share, by Dosage Form, 2022 & 2030 (%)
  • 8.3 Capsules and Tablets
    • 8.3.1 Overview
    • 8.3.2 Capsules and Tablets: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Powder
    • 8.4.1 Overview
    • 8.4.2 Powder: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Oil
    • 8.5.1 Overview
    • 8.5.2 Oil: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)

9. Global Vitamin K2 Market - Revenue and Forecast to 2030 - by Source.

  • 9.1 Overview
  • 9.2 Vitamin K2 Market Revenue Share, by Source, 2022 & 2030 (%)
  • 9.3 Natural
    • 9.3.1 Overview
    • 9.3.2 Natural: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Synthetic
    • 9.4.1 Overview
    • 9.4.2 Synthetic: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)

10. Global Vitamin K2 Market - Revenue and Forecast to 2030 - by Application.

  • 10.1 Overview
  • 10.2 Vitamin K2 Market Revenue Share, by Application, 2022 & 2030 (%)
  • 10.3 Pharmaceuticals
    • 10.3.1 Overview
    • 10.3.2 Pharmaceuticals: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Nutraceuticals and Food
    • 10.4.1 Overview
    • 10.4.2 Nutraceuticals and Food: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.5 Others
    • 10.5.1 Overview
    • 10.5.2 Others: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)

11. Vitamin K2 Market - Geographical Analysis

  • 11.1 North America: Vitamin K2 Market
    • 11.1.1 Overview
    • 11.1.2 North America: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
    • 11.1.3 North America: Vitamin K2 Market, by Product, 2020-2030 (US$ Million)
    • 11.1.4 North America: Vitamin K2 Market, by Dosage Form, 2020-2030 (US$ Million)
    • 11.1.5 North America: Vitamin K2 Market, by Source, 2020-2030 (US$ Million)
    • 11.1.6 North America: Vitamin K2 Market, by Application, 2020-2030 (US$ Million)
    • 11.1.7 North America: North America, by Country, 2022 & 2030 (%)
      • 11.1.7.1 US: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.7.1.1 Overview
        • 11.1.7.1.2 US: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.7.1.3 US: Vitamin K2 Market, by Product, 2020-2030 (US$ Million)
        • 11.1.7.1.4 US: Vitamin K2 Market, by Dosage Form, 2020-2030 (US$ Million)
        • 11.1.7.1.5 US: Vitamin K2 Market, by Source, 2020-2030 (US$ Million)
        • 11.1.7.1.6 US: Vitamin K2 Market, by Application, 2020-2030 (US$ Million)
      • 11.1.7.2 Canada: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.7.2.1 Overview
        • 11.1.7.2.2 Canada: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.7.2.3 Canada: Vitamin K2 Market, by Product, 2020-2030 (US$ Million)
        • 11.1.7.2.4 Canada: Vitamin K2 Market, by Dosage Form, 2020-2030 (US$ Million)
        • 11.1.7.2.5 Canada: Vitamin K2 Market, by Source, 2020-2030 (US$ Million)
        • 11.1.7.2.6 Canada: Vitamin K2 Market, by Application, 2020-2030 (US$ Million)
      • 11.1.7.3 Mexico: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.7.3.1 Overview
        • 11.1.7.3.2 Mexico: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.7.3.3 Mexico: Vitamin K2 Market, by Product, 2020-2030 (US$ Million)
        • 11.1.7.3.4 Mexico: Vitamin K2 Market, by Dosage Form, 2020-2030 (US$ Million)
        • 11.1.7.3.5 Mexico: Vitamin K2 Market, by Source, 2020-2030 (US$ Million)
        • 11.1.7.3.6 Mexico: Vitamin K2 Market, by Application, 2020-2030 (US$ Million)
  • 11.2 Europe Vitamin K2 Market, Revenue and Forecast to 2030
    • 11.2.1 Overview
    • 11.2.2 Europe Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.2.3 Europe Vitamin K2 Market, by Product
    • 11.2.4 Europe Vitamin K2 Market, by Dosage Form
    • 11.2.5 Europe Vitamin K2 Market, by Source
    • 11.2.6 Europe Vitamin K2 Market, by Application
    • 11.2.7 Europe Vitamin K2 Market by Country
      • 11.2.7.1 Germany
        • 11.2.7.1.1 Overview
        • 11.2.7.1.2 Germany Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.7.1.3 Germany Vitamin K2 Market, by Product
        • 11.2.7.1.4 Germany Vitamin K2 Market, by Dosage Form
        • 11.2.7.1.5 Germany Vitamin K2 Market, by Source
        • 11.2.7.1.6 Germany Vitamin K2 Market, by Application
      • 11.2.7.2 UK
        • 11.2.7.2.1 Overview
        • 11.2.7.2.2 UK Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.7.2.3 UK Vitamin K2 Market, by Product
        • 11.2.7.2.4 UK Vitamin K2 Market, by Dosage Form
        • 11.2.7.2.5 UK Vitamin K2 Market, by Source
        • 11.2.7.2.6 UK Vitamin K2 Market, by Application
      • 11.2.7.3 France
        • 11.2.7.3.1 Overview
        • 11.2.7.3.2 France Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.7.3.3 France Vitamin K2 Market, by Product
        • 11.2.7.3.4 France Vitamin K2 Market, by Dosage Form
        • 11.2.7.3.5 France Vitamin K2 Market, by Source
        • 11.2.7.3.6 France Vitamin K2 Market, by Application
      • 11.2.7.4 Italy
        • 11.2.7.4.1 Overview
        • 11.2.7.4.2 Italy Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.7.4.3 Italy Vitamin K2 Market, by Product
        • 11.2.7.4.4 Italy Vitamin K2 Market, by Dosage Form
        • 11.2.7.4.5 Italy Vitamin K2 Market, by Source
        • 11.2.7.4.6 Italy Vitamin K2 Market, by Application
      • 11.2.7.5 Spain
        • 11.2.7.5.1 Overview
        • 11.2.7.5.2 Spain Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.7.5.3 Spain Vitamin K2 Market, by Product
        • 11.2.7.5.4 Spain Vitamin K2 Market, by Dosage Form
        • 11.2.7.5.5 Spain Vitamin K2 Market, by Source
        • 11.2.7.5.6 Spain Vitamin K2 Market, by Application
      • 11.2.7.6 Rest of Europe
        • 11.2.7.6.1 Overview
        • 11.2.7.6.2 Rest of Europe Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.7.6.3 Rest of Europe Vitamin K2 Market, by Product
        • 11.2.7.6.4 Rest of Europe Vitamin K2 Market, by Dosage Form
        • 11.2.7.6.5 Rest of Europe Vitamin K2 Market, by Source
        • 11.2.7.6.6 Rest of Europe Vitamin K2 Market, by Application
  • 11.3 Asia Pacific: Vitamin K2 Market
    • 11.3.1 Overview
    • 11.3.2 Asia Pacific: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
    • 11.3.3 Asia Pacific: Vitamin K2 Market, by Product, 2020-2030 (US$ Million)
    • 11.3.4 Asia Pacific: Vitamin K2 Market, by Dosage Form, 2020-2030 (US$ Million)
    • 11.3.5 Asia Pacific: Vitamin K2 Market, by Source, 2020-2030 (US$ Million)
    • 11.3.6 Asia Pacific: Vitamin K2 Market, by Application, 2020-2030 (US$ Million)
    • 11.3.7 Asia Pacific: Vitamin K2 Market, by Country, 2022 & 2030 (%)
      • 11.3.7.1 China: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.1.1 Overview
        • 11.3.7.1.2 China: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.1.3 China: Vitamin K2 Market, by Product, 2020-2030 (US$ Million)
        • 11.3.7.1.4 China: Vitamin K2 Market, by Dosage Form, 2020-2030 (US$ Million)
        • 11.3.7.1.5 China: Vitamin K2 Market, by Source, 2020-2030 (US$ Million)
        • 11.3.7.1.6 China: Vitamin K2 Market, by Application, 2020-2030 (US$ Million)
      • 11.3.7.2 Japan: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.2.1 Overview
        • 11.3.7.2.2 Japan: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.2.3 Japan: Vitamin K2 Market, by Product, 2020-2030 (US$ Million)
        • 11.3.7.2.4 Japan: Vitamin K2 Market, by Dosage Form, 2020-2030 (US$ Million)
        • 11.3.7.2.5 Japan: Vitamin K2 Market, by Source, 2020-2030 (US$ Million)
        • 11.3.7.2.6 Japan: Vitamin K2 Market, by Application, 2020-2030 (US$ Million)
      • 11.3.7.3 India: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.3.1 Overview
        • 11.3.7.3.2 India: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.3.3 India: Vitamin K2 Market, by Product, 2020-2030 (US$ Million)
        • 11.3.7.3.4 India: Vitamin K2 Market, by Dosage Form, 2020-2030 (US$ Million)
        • 11.3.7.3.5 India: Vitamin K2 Market, by Source, 2020-2030 (US$ Million)
        • 11.3.7.3.6 India: Vitamin K2 Market, by Application, 2020-2030 (US$ Million)
      • 11.3.7.4 Australia: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.4.1 Overview
        • 11.3.7.4.2 Australia: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.4.3 Australia: Vitamin K2 Market, by Product, 2020-2030 (US$ Million)
        • 11.3.7.4.4 Australia Pacific Vitamin K2 Market, by Dosage Form, 2020-2030 (US$ Million)
        • 11.3.7.4.5 Australia Vitamin K2 Market, by Source, 2020-2030 (US$ Million)
        • 11.3.7.4.6 Australia Vitamin K2 Market, by Application, 2020-2030 (US$ Million)
      • 11.3.7.5 South Korea: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.5.1 Overview
        • 11.3.7.5.2 South Korea: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.5.3 South Korea: Vitamin K2 Market, by Product, 2020-2030 (US$ Million)
        • 11.3.7.5.4 South Korea Vitamin K2 Market, by Dosage Form, 2020-2030 (US$ Million)
        • 11.3.7.5.5 South Korea Vitamin K2 Market, by Source, 2020-2030 (US$ Million)
        • 11.3.7.5.6 South Korea Vitamin K2 Market, by Application, 2020-2030 (US$ Million)
      • 11.3.7.6 Rest of Asia Pacific: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.6.1 Overview
        • 11.3.7.6.2 Rest of Asia Pacific: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.6.3 Rest of Asia Pacific: Vitamin K2 Market, by Product, 2020-2030 (US$ Million)
        • 11.3.7.6.4 Rest of Asia Pacific Vitamin K2 Market, by Dosage Form, 2020-2030 (US$ Million)
        • 11.3.7.6.5 Rest of Asia Pacific Vitamin K2 Market, by Source, 2020-2030 (US$ Million)
        • 11.3.7.6.6 Rest of Asia Pacific Vitamin K2 Market, by Application, 2020-2030 (US$ Million)
  • 11.4 Middle East and Africa: Vitamin K2 Market
    • 11.4.1 Overview
    • 11.4.2 Middle East and Africa: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
    • 11.4.3 Middle East and Africa: Vitamin K2 Market, by Product, 2020-2030 (US$ Million)
    • 11.4.4 Middle East and Africa: Vitamin K2 Market, by Dosage Form, 2020-2030 (US$ Million)
    • 11.4.5 Middle East and Africa: Vitamin K2 Market, by Source, 2020-2030 (US$ Million)
    • 11.4.6 Middle East and Africa: Vitamin K2 Market, by Application, 2020-2030 (US$ Million)
    • 11.4.7 Middle East and Africa: Vitamin K2 Market, by Country, 2022 & 2030 (%)
      • 11.4.7.1 South Africa: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.7.1.1 Overview
        • 11.4.7.1.2 South Africa: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.7.1.3 South Africa: Vitamin K2 Market, by Product, 2020-2030 (US$ Million)
        • 11.4.7.1.4 South Africa: Vitamin K2 Market, by Dosage Form, 2020-2030 (US$ Million)
        • 11.4.7.1.5 South Africa: Vitamin K2 Market, by Source, 2020-2030 (US$ Million)
        • 11.4.7.1.6 South Africa: Vitamin K2 Market, by Application, 2020-2030 (US$ Million)
      • 11.4.7.2 Saudi Arabia: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.7.2.1 Overview
        • 11.4.7.2.2 Saudi Arabia: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.7.2.3 Saudi Arabia: Vitamin K2 Market, by Product, 2020-2030 (US$ Million)
        • 11.4.7.2.4 Saudi Arabia: Vitamin K2 Market, by Dosage Form, 2020-2030 (US$ Million)
        • 11.4.7.2.5 Saudi Arabia: Vitamin K2 Market, by Source, 2020-2030 (US$ Million)
        • 11.4.7.2.6 Saudi Arabia: Vitamin K2 Market, by Application, 2020-2030 (US$ Million)
      • 11.4.7.3 U.A.E: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.7.3.1 Overview
        • 11.4.7.3.2 U.A.E: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.7.3.3 U.A.E: Vitamin K2 Market, by Product, 2020-2030 (US$ Million)
        • 11.4.7.3.4 U.A.E: Vitamin K2 Market, by Dosage Form, 2020-2030 (US$ Million)
        • 11.4.7.3.5 U.A.E: Vitamin K2 Market, by Source, 2020-2030 (US$ Million)
        • 11.4.7.3.6 U.A.E: Vitamin K2 Market, by Application, 2020-2030 (US$ Million)
      • 11.4.7.4 Rest of Middle East and Africa: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.7.4.1 Overview
        • 11.4.7.4.2 Rest of Middle East and Africa: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.7.4.3 Rest of Middle East and Africa: Vitamin K2 Market, by Product, 2020-2030 (US$ Million)
        • 11.4.7.4.4 Rest of Middle East and Africa Vitamin K2 Market, by Dosage Form, 2020-2030 (US$ Million)
        • 11.4.7.4.5 Rest of Middle East and Africa Vitamin K2 Market, by Source, 2020-2030 (US$ Million)
        • 11.4.7.4.6 Rest of Middle East and Africa Vitamin K2 Market, by Application, 2020-2030 (US$ Million)
  • 11.5 South & Central America Vitamin K2 Market, Revenue and Forecast to 2030
    • 11.5.1 Overview
    • 11.5.2 South & Central America Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.5.3 South & Central America Vitamin K2 Market, by Product
    • 11.5.4 South & Central America Vitamin K2 Market, by Dosage Form
    • 11.5.5 South & Central America Vitamin K2 Market, by Source
    • 11.5.6 South & Central America Vitamin K2 Market, by Application
    • 11.5.7 South & Central America Vitamin K2 Market by Country
      • 11.5.7.1 Brazil
        • 11.5.7.1.1 Overview
        • 11.5.7.1.2 Brazil Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.5.7.1.3 Brazil Vitamin K2 Market, by Product
        • 11.5.7.1.4 Brazil Vitamin K2 Market, by Dosage Form
        • 11.5.7.1.5 Brazil Vitamin K2 Market, by End-User
        • 11.5.7.1.6 Brazil Vitamin K2 Market, by Application
      • 11.5.7.2 Argentina
        • 11.5.7.2.1 Overview
        • 11.5.7.2.2 Argentina Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.5.7.2.3 Argentina Vitamin K2 Market, by Product
        • 11.5.7.2.4 Argentina Vitamin K2 Market, by Dosage Form
        • 11.5.7.2.5 Argentina Vitamin K2 Market, by End-User
        • 11.5.7.2.6 Argentina Vitamin K2 Market, by Application
      • 11.5.7.3 Rest of South & Central America
        • 11.5.7.3.1 Overview
        • 11.5.7.3.2 Rest of South & Central America Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.5.7.3.3 Rest of South & Central America Vitamin K2 Market, by Product
        • 11.5.7.3.4 Rest of South & Central America Vitamin K2 Market, by Dosage Form
        • 11.5.7.3.5 Rest of South & Central America Vitamin K2 Market, by End-User
        • 11.5.7.3.6 Rest of South & Central America Vitamin K2 Market, by Application

12. Vitamin K2 Market Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in Vitamin K2 Market
  • 12.3 Organic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Inorganic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Lonza Group AG
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 International Flavors & Fragrances Inc
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Balchem Corp
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 BASF SE
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Lesaffre et Cie SA
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Seebio Biotech (Shanghai) Co Ltd
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Koninklijke DSM NV
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Novozymes AS
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Glanbia Plc
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Anderson Global Group LLC
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About Us
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. Vitamin K2 Market Segmentation
  • Table 2. North America Vitamin K2 Market, by Product- Revenue and Forecast to 2030 (US$ Million)
  • Table 3. North America Vitamin K2 Market, by Dosage Form- Revenue and Forecast to 2030 (US$ Million)
  • Table 4. North America Vitamin K2 Market, by Source - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. North America Vitamin K2 Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. US Vitamin K2 Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. US Vitamin K2 Market, by Dosage Form- Revenue and Forecast to 2030 (US$ Million)
  • Table 8. US Vitamin K2 Market, by Source- Revenue and Forecast to 2030 (US$ Million)
  • Table 9. US Vitamin K2 Market, by Application- Revenue and Forecast to 2030 (US$ Million)
  • Table 10. Canada Vitamin K2 Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Canada Vitamin K2 Market, by Dosage Form- Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Canada Vitamin K2 Market, by Source- Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Canada Vitamin K2 Market, by Application- Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Mexico Vitamin K2 Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Mexico Vitamin K2 Market, by Dosage Form- Revenue and Forecast to 2030 (US$ Million)
  • Table 16. Mexico Vitamin K2 Market, by Source- Revenue and Forecast to 2030 (US$ Million)
  • Table 17. Mexico Vitamin K2 Market, by Application- Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Product
  • Table 19. Europe Vitamin K2 Market Revenue And Forecast To 2030 (US$ Mn) - Surgery
  • Table 20. Europe Vitamin K2 Market Revenue And Forecast To 2030 (US$ Mn) - Source
  • Table 21. Europe Vitamin K2 Market Revenue And Forecast To 2030 (US$ Mn) - Application
  • Table 22. Germany Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Product
  • Table 23. Germany Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Surgery
  • Table 24. Germany Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Source
  • Table 25. Germany Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 26. UK Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Product
  • Table 27. UK Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Surgery
  • Table 28. UK Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Source
  • Table 29. UK Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 30. France Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Product
  • Table 31. France Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Surgery
  • Table 32. France Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - End-User
  • Table 33. France Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 34. Italy Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Product
  • Table 35. Italy Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Surgery
  • Table 36. Italy Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Source
  • Table 37. Italy Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 38. Spain Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Product
  • Table 39. Spain Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Surgery
  • Table 40. Spain Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Source
  • Table 41. Spain Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 42. Rest of Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Product
  • Table 43. Rest of Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Surgery
  • Table 44. Rest of Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Source
  • Table 45. Rest of Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 46. Asia Pacific Vitamin K2 Market, by Product- Revenue and Forecast to 2030 (US$ Million)
  • Table 47. Asia Pacific Vitamin K2 Market, by Dosage Form- Revenue and Forecast to 2030 (US$ Million)
  • Table 48. Asia Pacific Vitamin K2 Market, by Source - Revenue and Forecast to 2030 (US$ Million)
  • Table 49. Asia Pacific Vitamin K2 Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 50. China Vitamin K2 Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 51. China Vitamin K2 Market, by Dosage Form- Revenue and Forecast to 2030 (US$ Million)
  • Table 52. China Vitamin K2 Market, by Source- Revenue and Forecast to 2030 (US$ Million)
  • Table 53. China Vitamin K2 Market, by Application- Revenue and Forecast to 2030 (US$ Million)
  • Table 54. Japan Vitamin K2 Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 55. Japan Vitamin K2 Market, by Dosage Form- Revenue and Forecast to 2030 (US$ Million)
  • Table 56. Japan Vitamin K2 Market, by Source- Revenue and Forecast to 2030 (US$ Million)
  • Table 57. Japan Vitamin K2 Market, by Application- Revenue and Forecast to 2030 (US$ Million)
  • Table 58. India Vitamin K2 Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 59. India Vitamin K2 Market, by Dosage Form- Revenue and Forecast to 2030 (US$ Million)
  • Table 60. India Vitamin K2 Market, by Source- Revenue and Forecast to 2030 (US$ Million)
  • Table 61. India Vitamin K2 Market, by Application- Revenue and Forecast to 2030 (US$ Million)
  • Table 62. Australia Vitamin K2 Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 63. Australia Pacific Vitamin K2 Market, by Dosage Form- Revenue and Forecast to 2030 (US$ Million)
  • Table 64. Australia Vitamin K2 Market, by Source- Revenue and Forecast to 2030 (US$ Million)
  • Table 65. Australia Vitamin K2 Market, by Application- Revenue and Forecast to 2030 (US$ Million)
  • Table 66. South Korea Vitamin K2 Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 67. South Korea Vitamin K2 Market, by Dosage Form- Revenue and Forecast to 2030 (US$ Million)
  • Table 68. South Korea Vitamin K2 Market, by Source- Revenue and Forecast to 2030 (US$ Million)
  • Table 69. South Korea Vitamin K2 Market, by Application- Revenue and Forecast to 2030 (US$ Million)
  • Table 70. Rest of Asia Pacific Vitamin K2 Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 71. Rest of Asia Pacific Vitamin K2 Market, by Dosage Form- Revenue and Forecast to 2030 (US$ Million)
  • Table 72. Rest of Asia Pacific Vitamin K2 Market, by Source- Revenue and Forecast to 2030 (US$ Million)
  • Table 73. Rest of Asia Pacific Vitamin K2 Market, by Application- Revenue and Forecast to 2030 (US$ Million)
  • Table 74. Middle East and Africa Vitamin K2 Market, by Product- Revenue and Forecast to 2030 (US$ Million)
  • Table 75. Middle East and Africa Vitamin K2 Market, by Dosage Form- Revenue and Forecast to 2030 (US$ Million)
  • Table 76. Middle East and Africa Vitamin K2 Market, by Source - Revenue and Forecast to 2030 (US$ Million)
  • Table 77. Middle East and Africa Vitamin K2 Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 78. South Africa Vitamin K2 Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 79. South Africa Vitamin K2 Market, by Dosage Form- Revenue and Forecast to 2030 (US$ Million)
  • Table 80. South Africa Vitamin K2 Market, by Source- Revenue and Forecast to 2030 (US$ Million)
  • Table 81. South Africa Vitamin K2 Market, by Application- Revenue and Forecast to 2030 (US$ Million)
  • Table 82. Saudi Arabia Vitamin K2 Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 83. Saudi Arabia Vitamin K2 Market, by Dosage Form- Revenue and Forecast to 2030 (US$ Million)
  • Table 84. Saudi Arabia Vitamin K2 Market, by Source- Revenue and Forecast to 2030 (US$ Million)
  • Table 85. Saudi Arabia Vitamin K2 Market, by Application- Revenue and Forecast to 2030 (US$ Million)
  • Table 86. U.A.E Vitamin K2 Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 87. U.A.E Vitamin K2 Market, by Dosage Form- Revenue and Forecast to 2030 (US$ Million)
  • Table 88. U.A.E Vitamin K2 Market, by Source- Revenue and Forecast to 2030 (US$ Million)
  • Table 89. U.A.E Vitamin K2 Market, by Application- Revenue and Forecast to 2030 (US$ Million)
  • Table 90. Rest of Middle East and Africa Vitamin K2 Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 91. Rest of Middle East and Africa Vitamin K2 Market, by Dosage Form- Revenue and Forecast to 2030 (US$ Million)
  • Table 92. Rest of Middle East and Africa Vitamin K2 Market, by Source- Revenue and Forecast to 2030 (US$ Million)
  • Table 93. Rest of Middle East and Africa Vitamin K2 Market, by Application- Revenue and Forecast to 2030 (US$ Million)
  • Table 94. South & Central America Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 95. South & Central America Vitamin K2 Market Revenue and Forecast To 2030 (US$ Mn) - Surgery
  • Table 96. South & Central America Vitamin K2 Market Revenue and Forecast To 2030 (US$ Mn) - Source
  • Table 97. South & Central America Vitamin K2 Market Revenue and Forecast To 2030 (US$ Mn) - Application
  • Table 98. Brazil Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 99. Brazil Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn) - Surgery
  • Table 100. Brazil Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn) - End-User
  • Table 101. Brazil Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 102. Argentina Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 103. Argentina Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn) - Surgery
  • Table 104. Argentina Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn) - End-User
  • Table 105. Argentina Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 106. Rest of South & Central America Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 107. Rest of South & Central America Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn) - Surgery
  • Table 108. Rest of South & Central America Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn) - End-User
  • Table 109. Rest of South & Central America Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 110. Recent Organic Growth Strategies in Vitamin K2 Market
  • Table 111. Recent Inorganic Growth Strategies in the Vitamin K2 Market
  • Table 112. Glossary of Terms, Vitamin K2 Market

List Of Figures

  • Figure 1. Vitamin K2 Market Segmentation, By Geography
  • Figure 2. North America - PEST Analysis
  • Figure 3. Vitamin K2 Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. Vitamin K2 Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. Vitamin K2 Market Revenue Share, by Product 2022 & 2030 (%)
  • Figure 7. MK-4: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. MK-7: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Combination Drugs: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Vitamin K2 Market Revenue Share, by Dosage Form 2022 & 2030 (%)
  • Figure 11. Capsules and Tablets: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Powder: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Oil: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Vitamin K2 Market Revenue Share, by Source 2022 & 2030 (%)
  • Figure 15. Natural: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Synthetic: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Vitamin K2 Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 18. Pharmaceuticals: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Nutraceuticals and Food: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Others: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. North America: Vitamin K2 Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 22. North America Vitamin K2 Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. North America: North America, by Country, 2022 & 2030 (%)
  • Figure 24. US: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Canada: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Mexico: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Europe Vitamin K2 Market, By Geography, 2022 ($Mn)
  • Figure 28. Europe Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 29. Europe Vitamin K2 Market, By Key Countries, 2022 And 2030 (%)
  • Figure 30. AS is the most common valvular heart disease, with a dismal prognosis when untreated. Recommended therapy is SAVR or TAVR.
  • Figure 31. Germany Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 32. UK Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 33. France Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 34. Italy Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 35. Spain Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 36. Rest of Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 37. Asia Pacific: Vitamin K2 Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 38. Asia Pacific Vitamin K2 Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 39. Asia Pacific: Vitamin K2 Market, by Country, 2022 & 2030 (%)
  • Figure 40. China: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 41. Japan: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 42. India: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 43. Australia: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 44. South Korea: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 45. Rest of Asia Pacific: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 46. Middle East and Africa: Vitamin K2 Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 47. Middle East and Africa Vitamin K2 Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 48. Middle East and Africa: Vitamin K2 Market, by Country, 2022 & 2030 (%)
  • Figure 49. South Africa: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 50. Saudi Arabia: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 51. U.A.E: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 52. Rest of Middle East and Africa: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 53. Vitamin K2 Market, By Geography, 2022 ($Mn)
  • Figure 54. South & Central America Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 55. South & Central America Vitamin K2 Market, By Key Countries, 2022 and 2030 (%)
  • Figure 56. Brazil Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 57. Argentina Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 58. Rest of South & Central America Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 59. Growth Strategies in Vitamin K2 Market